Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2010
06/15/2010US7737154 CRF receptor antagonists and methods relating thereto
06/15/2010US7737153 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
06/15/2010US7737145 Diamine derivatives as inhibitors of leukotriene A4 hydrolase
06/15/2010US7737144 1-Ethyl-6-methyl-3-phenyl-1H-pyrinido[5,4-e]1,2,4]triazine-5,7-dione, used for lowering blood sugar, treating non-insulin dependent diabetes and insulin resistance; antidiabetic agents
06/15/2010CA2518224C Novel isothiazolopyrimidinones and isoxazolopyrimidinones and uses thereof
06/15/2010CA2419875C 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives
06/10/2010WO2010065898A2 Egfr kinase knockdown via electrophilically enhanced inhibitors
06/10/2010WO2010065690A1 Crystalline forms
06/10/2010WO2010065134A1 5, 7-dihydro- 6h-pyrimido [ 5, 4-d] [ 1 ] benzazepin-6-thiones as plk inhibitors
06/10/2010WO2010064134A2 Process of synthesis of paliperidone
06/10/2010WO2010064020A1 Imidazopyridine compounds
06/10/2010WO2010063634A1 Pyrrolopyrazinyl urea kinase inhibitors
06/10/2010WO2010063487A1 Pyrazolopyrimidines, a process for their preparation and their use as medicine
06/10/2010WO2010036404A3 Novel retinamide retinoic acid metabolism blocking agents
06/10/2010WO2010028105A3 Amorphous pemetrexed disodium
06/10/2010WO2010021934A3 Azaindole inhibitors of iap
06/10/2010US20100145048 Compounds for the treatment of inflammatory disorders
06/10/2010US20100145045 Use of fungicides for the treatment of fish mycoses
06/10/2010US20100144823 Novel indole derivatives as selective androgen receptor modulators (sarms)
06/10/2010US20100144820 Therapeutic hpph dosage for pdt
06/10/2010US20100144764 Pyrimidinedione derivatives and methods of use thereof
06/10/2010US20100144758 Azaindole p2x3 and p2x2/3 modulators
06/10/2010US20100144744 Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
06/10/2010US20100144741 Ethanolamine derivatives useful as bace inhibitors
06/10/2010US20100144739 Heterocyclic inhibitors of c-met and uses thereof
06/10/2010US20100144738 Inhibitors of c-met and uses thereof
06/10/2010US20100144730 Pyridinonyl pdk1 inhibitors
06/10/2010US20100144714 Derivatives of imidazo pyrimido and diazepine pyrimidine-dione, and use thereof as a drug
06/10/2010US20100144705 Egfr kinase knockdown via electrophilically enhanced inhibitors
06/10/2010US20100144700 Heterocyclic-carbonyl-diazabicycloalkanes as modulators of the neuronal nicotinic acetylcholine alpha 4 beta 2, subtype receptor for the treatment of cns related disorders
06/10/2010US20100144608 Macrocyclic hepatitis C serine protease inhibitors
06/10/2010US20100144594 2-heteroaryl-pyrrolo[3,4-c]pyrrole derivatives and their use as scd inhibitors
06/10/2010US20100143384 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES AS CYCLIN DEPENDENT KINASE INHIBITORS
06/10/2010US20100143301 Modulators of toll-like receptors
06/10/2010US20100143251 Compounds and amyloid probes thereof for therapeutic and imaging uses
06/10/2010CA2745262A1 Crystalline forms
06/10/2010CA2744507A1 Pyrrolopyrazinyl urea kinase inhibitors
06/09/2010EP2194058A1 Pyrazolopyrimidines suitable for the treatment of cancer diseases
06/09/2010EP2194054A1 Ligands for G-protein coupled receptors
06/09/2010EP2193131A2 Imidazo[1,2-a]pyrazine compounds for treatment of viral infections such as hepatitis
06/09/2010EP2193121A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
06/09/2010EP2192899A1 Transition metal complexes of corroles for preventing cardiovascular diseases or disorders
06/09/2010EP2097374B1 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy as selective ligands of v2 vasopressin receptors
06/09/2010EP1934224B1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors for the treatment of cancer
06/09/2010CN1939919B Low-toxic and broad-spectrum phthalocyanine bactericide, its production and use
06/09/2010CN1882589B Novel heterocyclic compounds as HSP90-inhibitors
06/09/2010CN1852712B Dual NK1/NK3 antagonists for treating schizophrenia
06/09/2010CN1780835B Novel fused heterocycles and uses thereof
06/09/2010CN101730700A Condensed heterocyclic compounds as inhibitors of protein kinases
06/09/2010CN101730699A Fused heterocyclic compounds useful for the treatment of proliferative, allergic, autoimmune or inflammatory diseases
06/09/2010CN101730698A Compounds for the treatment of hepatitis c
06/09/2010CN101730692A Pyridazinone derivatives useful as glucan synthase inhibitors
06/09/2010CN101723949A Polycyclic agents for the treatment of respiratory syncytial virus infections
06/09/2010CN101723948A C-6 modified indazolylpyrrolotriazines
06/09/2010CN101723947A Dipeptidase-IV inhibitor compound
06/09/2010CN101723946A Novel alkaline functional ion liquid and preparation method thereof
06/09/2010CN101723900A Cinnamide compound
06/09/2010CN101721963A Flexible formaldehyde windpipe and bracket in methenamine reactor
06/08/2010US7732610 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
06/08/2010US7732604 Triazolopyrazine derivatives
06/08/2010US7732603 Organic compounds as agents for the treatment of aldosterone mediated conditions
06/08/2010US7732599 from neopterin and/or 6-substituted pterins with improved yield and high stereoselectivity; reduction catalysts
06/08/2010US7732477 2-heteroarylcarboxylic acid amides
06/08/2010US7732473 Compounds with nootropic action, their preparation, pharmaceutical compositions containing them, and use thereof
06/08/2010US7732466 5-chloro-thiophene-2-carboxylic acid-N-{1-[3-chloro-4-(pyrrolidin-1-yl-carbonyl)-phenylcarbamoly]-ethyl}-amide, having antithrombotic activity and blood-coagulation factor Xa inhibiting activity
06/08/2010US7732456 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders
06/08/2010US7732454 Inhibitors of Bruton's tyrosine kinase
06/08/2010US7732438 CGRP receptor antagonists
06/08/2010US7732437 Such as 3-[2-[4-(11,12-dihydro-6H-benzimidazo[2,1-b][3]benzazepin-6-yl)-2-(phenyl-methyl)-1-piperidinyl]ethyl]-2,10-dimethyl pyrimido[1,2- alpha ]benzimidazol-4(10H)-one
06/08/2010US7732436 5-(2-amino-5-oxo-1,5-dihydro-imidazol-4-ylidene)-3,4,5,10-tetrahydro-2H-azepino[3,4-b]indol-1-one, used for treating inflammatory disorders selected from arthritis, inflammatory bowel disease, asthma, dermatitis and transplant rejection; inhibiting production of a cytokine in cells; enzyme inhibitors
06/08/2010US7732435 vanilloid receptor antagonists such as 7-(4-Chlorophenyl)-6-isopropyl-3-methyl-2,3-dihydro-1H-1-aza-4,5-dioxa-phenanthren-8-one, used for treating nociceptive pain; analgesics
06/08/2010CA2440553C 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
06/08/2010CA2433453C Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists
06/03/2010WO2010062571A1 Mtor kinase inhibitors for oncology indications and diseases associated with the mtor/p13k/akt pathway
06/03/2010WO2010061329A1 3-aminocyclopentanecarboxamides as chemokine receptor modulators
06/03/2010WO2010060968A1 Regioselective reduction of fused pyrrolocarbazoles-5,7-diones
06/03/2010WO2010060952A1 6,7,8,9-tetrahydro-5h-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
06/03/2010WO2010060854A1 Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
06/03/2010WO2010060836A1 Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists
06/03/2010WO2010060472A1 Imidazopyridazine derivatives acting as orexin antagonists
06/03/2010WO2010060471A1 Piperidine derivatives useful as orexin receptor antagonists
06/03/2010WO2010060470A1 Piperidine derivatives useful as orexin receptor antagonists
06/03/2010WO2010042392A3 Hiv integrase inhibitors
06/03/2010WO2010042391A3 Hiv integrase inhibitors
06/03/2010WO2010009210A3 Acetylsalicyclic acid derivatives useful to treat metabolic syndromes
06/03/2010WO2009154300A3 Heterocyclic compound and use thereof
06/03/2010US20100137614 Oligonucleotide conjugates; peptide nucleic acids; sequencing; for treating cancer; 3-[(tert-butyl)oxycarbonyl]-7-[(2,3,4,5,6-pentafluoropheny)oxycarbonyl]pyrrolo[3,2-e]indoline-5-sulfonic acid
06/03/2010US20100137599 Process for preparing 1,4-butandiol monitrate
06/03/2010US20100137585 Fused heteroaryl derivatives
06/03/2010US20100137584 Fused heteroaryl derivatives
06/03/2010US20100137343 Substituted quinazolines
06/03/2010US20100137340 Fused pyrimidinone compounds as mglur ligands
06/03/2010US20100137339 Amorphous form of n--n-methyl-acetamide
06/03/2010US20100137326 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES AS CYCLIN DEPENDENT KINASE INHIBITORS
06/03/2010US20100137321 IMIDAZO[1,2-a]AZINES AND THEIR USE AS PHARMACEUTICALS
06/03/2010US20100137320 Gamma secretase modulators
06/03/2010US20100137319 Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
06/03/2010US20100137318 Bicyclic heterocyclic compound
06/03/2010US20100137306 Heterocyclic trpv1 receptor ligands
06/03/2010US20100137288 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
1 ... 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 ... 573